BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 2882236)

  • 1. Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis?
    Poupon R; Chrétien Y; Poupon RE; Ballet F; Calmus Y; Darnis F
    Lancet; 1987 Apr; 1(8537):834-6. PubMed ID: 2882236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement of biliary enzyme levels and itching as a result of long-term administration of ursodeoxycholic acid in primary biliary cirrhosis.
    Matsuzaki Y; Tanaka N; Osuga T; Aikawa T; Shoda J; Doi M; Nakano M
    Am J Gastroenterol; 1990 Jan; 85(1):15-23. PubMed ID: 1967512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ursodeoxycholic acid for the treatment of primary biliary cirrhosis. Interim analysis of a double-blind multicentre randomized trial. The UDCA-PBC Study Group.
    Poupon RE; Eschwège E; Poupon R
    J Hepatol; 1990 Jul; 11(1):16-21. PubMed ID: 1975819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multi-center double-blind controlled trial of ursodeoxycholic acid for primary biliary cirrhosis.
    Oka H; Toda G; Ikeda Y; Hashimoto N; Hasumura Y; Kamimura T; Ohta Y; Tsuji T; Hattori N; Namihisa T
    Gastroenterol Jpn; 1990 Dec; 25(6):774-80. PubMed ID: 1980654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ursodeoxycholic acid treatment in primary biliary cirrhosis with the emphasis on late stage disease.
    Kneppelhout JC; Mulder CJ; van Berge Henegouwen GP; de Vries RA; Brandt KH
    Neth J Med; 1992 Aug; 41(1-2):11-6. PubMed ID: 1407234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bile acid glycine and taurine conjugates in serum of patients with primary biliary cirrhosis: effect of ursodeoxycholic treatment.
    Chretien Y; Poupon R; Gherardt MF; Chazouilleres O; Labbe D; Myara A; Trivin F
    Gut; 1989 Aug; 30(8):1110-5. PubMed ID: 2767508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of ursodeoxycholic acid administration on biliary lipid secretion in primary biliary cirrhosis.
    Roda E; Mazzella G; Bazzoli F; Villanova N; Minutello A; Simoni P; Ronchi M; Poggi C; Festi D; Aldini R
    Dig Dis Sci; 1989 Dec; 34(12 Suppl):52S-58S. PubMed ID: 2598768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biliary bile acids in primary biliary cirrhosis: effect of ursodeoxycholic acid.
    Combes B; Carithers RL; Maddrey WC; Munoz S; Garcia-Tsao G; Bonner GF; Boyer JL; Luketic VA; Shiffman ML; Peters MG; White H; Zetterman RK; Risser R; Rossi SS; Hofmann AF
    Hepatology; 1999 Jun; 29(6):1649-54. PubMed ID: 10347103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ursodeoxycholic acid in primary biliary cirrhosis: no evidence for toxicity in the stages I to III.
    Lotterer E; Stiehl A; Raedsch R; Foelsch UR; Bircher J
    J Hepatol; 1990 May; 10(3):284-90. PubMed ID: 2365981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ursodeoxycholic acid in the treatment of primary biliary cirrhosis: a short-term, randomized, double-blind controlled, cross-over study with long-term follow up.
    Hwang SJ; Chan CY; Lee SD; Wu JC; Tsay SH; Lo KJ
    J Gastroenterol Hepatol; 1993; 8(3):217-23. PubMed ID: 8100153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimum dose of ursodeoxycholic acid in primary biliary cirrhosis.
    Verma A; Jazrawi RP; Ahmed HA; Davis T; Bland JM; Benson M; Orchard RT; Theodossi A; Maxwell JD; Northfield TC
    Eur J Gastroenterol Hepatol; 1999 Oct; 11(10):1069-76. PubMed ID: 10524634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of ursodeoxycholic acid treatment on primary biliary cirrhosis].
    Raedsch R; Stiehl A; Hopf U; Möller B
    Z Gastroenterol Verh; 1989 Jul; 24():125-7. PubMed ID: 2474923
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of ursodeoxycholic acid on bile acid metabolism in primary biliary cirrhosis.
    Batta AK; Salen G; Arora R; Shefer S; Tint GS; Abroon J; Eskreis D; Katz S
    Hepatology; 1989 Oct; 10(4):414-9. PubMed ID: 2777202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholic acid and ursodeoxycholic acid therapy in primary biliary cirrhosis. Changes in bile acid patterns and their correlation with liver function.
    Güldütuna S; Leuschner M; Wunderlich N; Nickel A; Bhatti S; Hübner K; Leuschner U
    Eur J Clin Pharmacol; 1993; 45(3):221-5. PubMed ID: 8276045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicentre randomized placebo-controlled trial of ursodeoxycholic acid with or without colchicine in symptomatic primary biliary cirrhosis.
    Almasio PL; Floreani A; Chiaramonte M; Provenzano G; Battezzati P; Crosignani A; Podda M; Todros L; Rosina F; Saccoccio G; Manenti F; Ballardini G; Bianchi FP; Scheuer PJ; Davies SE; Craxì A
    Aliment Pharmacol Ther; 2000 Dec; 14(12):1645-52. PubMed ID: 11121914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized trial in primary biliary cirrhosis comparing ursodeoxycholic acid in daily doses of either 10 mg/kg or 20 mg/kg. Dutch Multicentre PBC Study Group.
    Van Hoogstraten HJ; De Smet MB; Renooij W; Breed JG; Engels LG; Den Ouden-Muller JW; Rijk MC; Smit AM; Zwertbroek R; Hop WC; van Berge Henegouwen GP; Schalm SW; van Buuren HR
    Aliment Pharmacol Ther; 1998 Oct; 12(10):965-71. PubMed ID: 9798800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A placebo-controlled trial of primary biliary cirrhosis treatment with colchicine and ursodeoxycholic acid.
    Vuoristo M; Färkkilä M; Karvonen AL; Leino R; Lehtola J; Mäkinen J; Mattila J; Friman C; Seppälä K; Tuominen J
    Gastroenterology; 1995 May; 108(5):1470-8. PubMed ID: 7729640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different response to ursodeoxycholic acid (UDCA) in primary biliary cirrhosis according to severity of disease.
    Floreani A; Zappalà F; Mazzetto M; Naccarato R; Plebani M; Chiaramonte M
    Dig Dis Sci; 1994 Jan; 39(1):9-14. PubMed ID: 8281873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group.
    Poupon RE; Balkau B; Eschwège E; Poupon R
    N Engl J Med; 1991 May; 324(22):1548-54. PubMed ID: 1674105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in the efficacy of ursodeoxycholic acid and bile acid metabolism between viral liver diseases and primary biliary cirrhosis.
    Nakashima T; Yoh T; Sumida Y; Kakisaka Y; Mitsuyoshi H
    J Gastroenterol Hepatol; 2001 May; 16(5):541-7. PubMed ID: 11350551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.